A safety, tolerability, pharmacokinetics, and pharmacodynamic multiple ascending dose study of VTP-27999 in salt-dependent healthy volunteers
Latest Information Update: 28 Feb 2017
At a glance
- Drugs VTP 27999 (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Vitae Pharmaceuticals
Most Recent Events
- 03 Dec 2015 New trial record